Amgen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€247.25
Target price
02.05.26
€283.33
Performance (%)
29.20%
Price
23:26
€312.30
Summary
This prediction is currently active. The prediction currently has a performance of 29.20%. A total of €7.14 was paid as dividends for this prediction. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 8.288% | 8.288% |
| iShares Core DAX® | -1.020% | 0.271% |
| iShares Nasdaq 100 | -3.122% | -1.929% |
| iShares Nikkei 225® | 0.649% | 6.582% |
| iShares S&P 500 | -0.142% | -0.295% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $324.00 to $320.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat